Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Adjustment Disorder With Anxious Mood
Clinical Trial
NCT04404192Last updated: 12/4/2025
VTGN
Vistagen Therapeutics, Inc.